Topical doxycycline monohydrate hydrogel 1% targeting proteases/PAR2 pathway is a novel therapeutic for atopic dermatitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Topical doxycycline monohydrate hydrogel 1% targeting proteases/PAR2 pathway is a novel therapeutic for atopic dermatitis

Published:2020-10-15 Issue:12 Volume:29 Page:1171-1175
ISSN:0906-6705
Container-title:Experimental Dermatology
language:en
Short-container-title:Exp Dermatol

Author:

Bohannon Mary¹,Liu Mingjin²,Nadeau Peter¹,Talton Judy³,Gibson Daniel⁴,Datta Susmita²,Schultz Gregory⁴,Talton James³,De Benedetto Anna¹^ORCID

Affiliation:

1. Department of Dermatology College of Medicine University of Florida Gainesville FL USA

2. Department of Biostatistics, Public Health and Health Professions and School of Medicine University of Florida Gainesville FL USA

3. Alchem Laboratories Corp. Alachua FL USA

4. Institute for Wound Research College of Medicine University of Florida Gainesville FL USA

Publisher

Wiley

Subject

Dermatology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/exd.14201

Reference21 articles.

1. Atopic Dermatitis

2. Cost of atopic dermatitis and eczema in the United States

3. Economic burden of cutaneous infections in children and adults with atopic dermatitis

4. Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis

5. Cutaneous barrier dysfunction in allergic diseases

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and emerging drugs for the treatment of pruritus: an update of the literature;Expert Opinion on Pharmacotherapy;2024-04-12

2. Hydrogels: a promising therapeutic platform for inflammatory skin diseases treatment;Journal of Materials Chemistry B;2024

3. Topical niclosamide (ATx201) reduces Staphylococcus aureus colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in a randomized, double‐blind, placebo‐controlled Phase 2 trial;Clinical and Translational Medicine;2022-05

4. Idiopathic Rhinitis in dogs - an Update;KLEINTIERPRAXIS;2022

5. In search of the needle in a haystack: Finding a suitable serum biomarker for monitoring disease activity of systemic sclerosis;Experimental Dermatology;2021-06-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3